An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)

NCT02623699 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Tofersen
DRUG: Placebo

Sponsor

Biogen

Collaborators

[object Object]